Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IDX12899 in treatment-naive adults with chronic HIV-1 infection
ISRCTN89417804Phase 2Completed
- Sponsor
- Idenix Pharmaceuticals
- Start
- Jan 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in Human immunodeficiency virus infection type 1 comparing IDX12899 with Placebo (2 arms). Primary endpoints: Proportion of subjects experiencing adverse events and laboratory abnormalities and Decrease from baseline in plasma HIV-1 RNA. Started Jan 2008; status: completed.
02
Drugs
Fosdevirine
03
Conditions
Human immunodeficiency virus infection type 1
Beyond the preview
Go deeper on ISRCTN89417804.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN89417804.